- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05279729
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
September 30, 2025 updated by: San Diego State University
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic
The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and the subsequent benefit of improving type II diabetes outcomes in a low socioeconomic Hispanic population.
This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92182
- Recruiting
- San Diego State University
-
Contact:
- Mee Young Hong, PhD
- Phone Number: 619-594-2392
- Email: mhong2@sdsu.edu
-
Contact:
- Robert J Castro, BS
- Phone Number: 6193636120
- Email: rcastro0271@sdsu.edu
-
Principal Investigator:
- Mee Young Hong, PhD
-
Principal Investigator:
- Robert J Castro, BS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Diagnosed with type II diabetes
- Between the age of 18-64
- BMI ≥ 27
- Individual annual income less than $47,520 [Covered CA income guidelines and salary restrictions]
- Hispanic and/or Latinx origin
- Monitors blood glucose regularly
- Owns or has access to a bathroom weight scale
- Owns a smartphone and willing to download mobile apps
Exclusion Criteria:
- Does not check blood glucose at least once per day
- On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications.
Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are okay
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Experimental: Weight Watchers (WW)
|
Intervention will be with two different mobile health (mHealth) applications, Weight Watchers and Healthi app (formerly iTrackBites)
|
|
Experimental: Healthi app
|
Intervention will be with two different mobile health (mHealth) applications, Weight Watchers and Healthi app (formerly iTrackBites)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effectiveness of mHealth apps at reducing bodyweight assessed by bodyweight measurements over 6 months
Time Frame: 6 months
|
Determine if mHealth apps-Weight Watchers (WW) and Healthi app-are an effective weight loss modality compared to standard weight loss program (control)
|
6 months
|
|
Most effect intervention for weight loss in first 3 months
Time Frame: 6 months
|
Compare the three interventions, mHealth apps and control, against each other to determine which is most effective at achieving the maximum amount of weight loss within the first three months
|
6 months
|
|
Most effective intervention for weight loss by 6 months
Time Frame: 6 months
|
Compare and determine which intervention leads to the highest weight loss maintenance after six months
|
6 months
|
|
Self-efficacy in weight management assessed by Weight Management and Nutrition Knowledge questionnaire
Time Frame: 6 months
|
Compare and determine which intervention promotes self-efficacy in weight management
|
6 months
|
|
Long term diabetes improvement via A1c
Time Frame: 6 months
|
Compare and determine which intervention provides the best improvements towards diabetes via blood glucose and HbA1c
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life after using mHealth apps assessed by World Health Organization Quality of Life BREF questionnaire
Time Frame: 6 months
|
Comparing the three interventions to determine which leads to greater quality of life (QOL)
|
6 months
|
|
mhealthy app preference assessed by questionnaire
Time Frame: 6 months
|
Which mHealth app is more economically feasible for the participants and if feasibility changes after app usage.
Outcome will be assessed with a questionnaire asking if the participant can afford the app.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2022
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
February 23, 2022
First Submitted That Met QC Criteria
March 6, 2022
First Posted (Actual)
March 15, 2022
Study Record Updates
Last Update Posted (Estimated)
October 6, 2025
Last Update Submitted That Met QC Criteria
September 30, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HS-2021-0245
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Mobile health application
-
Saglik Bilimleri UniversitesiGümüşhane UniversıtyNot yet recruitingMobile Application | End-Stage Renal Disease Requiring HaemodialysisTurkey (Türkiye)
-
Texas A&M UniversityCompletedStress | Anxiety | Depression - Major Depressive DisorderUnited States
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); Ohio State UniversityCompletedSickle Cell DiseaseUnited States
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States
-
University of CadizCompleted
-
University of LincolnLincolnshire Partnership NHS Foundation TrustCompletedPsychological DistressUnited Kingdom
-
Hospital Clinic of BarcelonaCompletedChronic Disease | Multiple Chronic ConditionsSpain
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedHIV/AIDS | Mobile Health | Young AdultsUnited States
-
Yibelu Bazezew BitewaCompletedPerinatal Outcomes | Maternal Outcomes | Maternity Continuum of Care | Obstetric Health LiteracyEthiopia
-
University of MinnesotaCompletedHealthy Children (1 Month to 17 Years Old)United States